These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 26438881)

  • 1. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
    Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the EGF receptor in vascular smooth muscle cells prevents chronic angiotensin II-induced arterial wall stiffening and media thickening.
    Schreier B; Hünerberg M; Mildenberger S; Rabe S; Bethmann D; Wickenhauser C; Gekle M
    Acta Physiol (Oxf); 2018 Mar; 222(3):. PubMed ID: 29152859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor is critical for angiotensin II-mediated hypertrophy in cerebral arterioles.
    Chan SL; Umesalma S; Baumbach GL
    Hypertension; 2015 Apr; 65(4):806-12. PubMed ID: 25733240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VSMC-Specific Deletion of FAM3A Attenuated Ang II-Promoted Hypertension and Cardiovascular Hypertrophy.
    Xiang R; Chen J; Li S; Yan H; Meng Y; Cai J; Cui Q; Yang Y; Xu M; Geng B; Yang J
    Circ Res; 2020 Jun; 126(12):1746-1759. PubMed ID: 32279581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation.
    Bourmoum M; Charles R; Claing A
    PLoS One; 2016; 11(1):e0148097. PubMed ID: 26824355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of epidermal growth factor receptor in vascular smooth muscle cells and cardiomyocytes causes arterial hypotension and cardiac hypertrophy.
    Schreier B; Rabe S; Schneider B; Bretschneider M; Rupp S; Ruhs S; Neumann J; Rueckschloss U; Sibilia M; Gotthardt M; Grossmann C; Gekle M
    Hypertension; 2013 Feb; 61(2):333-40. PubMed ID: 23248150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transactivation of epidermal growth factor receptor by enhanced levels of endogenous angiotensin II contributes to the overexpression of Giα proteins in vascular smooth muscle cells from SHR.
    Sandoval YH; Li Y; Anand-Srivastava MB
    Cell Signal; 2011 Nov; 23(11):1716-26. PubMed ID: 21712088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
    Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL
    Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells.
    Yoshimoto T; Fukai N; Sato R; Sugiyama T; Ozawa N; Shichiri M; Hirata Y
    Endocrinology; 2004 Jul; 145(7):3331-7. PubMed ID: 15070851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of epidermal growth factor receptor (ErbB1) loss for vascular smooth muscle cells from mice with targeted deletion of ErbB1.
    Schreier B; Döhler M; Rabe S; Schneider B; Schwerdt G; Ruhs S; Sibilia M; Gotthardt M; Gekle M; Grossmann C
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1643-52. PubMed ID: 21512163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7.
    Li Y; Li H; Xing W; Li J; Du R; Cao D; Wang Y; Yang X; Zhong G; Zhao Y; Sun W; Liu C; Gao X; Li Y; Liu Z; Jin X; Zhao D; Tan Y; Wang Y; Liu S; Yuan M; Song J; Chang YZ; Gao F; Ling S; Li Y
    FASEB J; 2021 Nov; 35(11):e21947. PubMed ID: 34637552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of epidermal growth factor receptor transactivation in angiotensin II-induced enhanced expression of Gi protein and proliferation in A10 vascular smooth muscle cells.
    Gomez Sandoval YH; Lévesque LO; Anand-Srivastava MB
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1037-45. PubMed ID: 20029540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance-specific importance of EGFR for vascular smooth muscle cells motility in primary culture.
    Schreier B; Schwerdt G; Heise C; Bethmann D; Rabe S; Mildenberger S; Gekle M
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1519-33. PubMed ID: 27012600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, alphavbeta3-integrin, and TGF-beta1 in response to ANG II and high glucose.
    Belmadani S; Zerfaoui M; Boulares HA; Palen DI; Matrougui K
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H69-76. PubMed ID: 18456735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells.
    Harrison CB; Trevelin SC; Richards DA; Santos CXC; Sawyer G; Markovinovic A; Zhang X; Zhang M; Brewer AC; Yin X; Mayr M; Shah AM
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):698-710. PubMed ID: 33054395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
    Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
    Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species.
    Kirabo A; Kearns PN; Jarajapu YP; Sasser JM; Oh SP; Grant MB; Kasahara H; Cardounel AJ; Baylis C; Wagner KU; Sayeski PP
    Cardiovasc Res; 2011 Jul; 91(1):171-9. PubMed ID: 21354995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats.
    Nagareddy PR; MacLeod KM; McNeill JH
    Cardiovasc Res; 2010 Jul; 87(1):177-86. PubMed ID: 20110336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
    Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells.
    Shimizu H; Hirose Y; Goto S; Nishijima F; Zrelli H; Zghonda N; Niwa T; Miyazaki H
    Life Sci; 2012 Sep; 91(5-6):172-7. PubMed ID: 22781707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.